2022
DOI: 10.3390/molecules27134183
|View full text |Cite
|
Sign up to set email alerts
|

Dimethyl Itaconate Reduces α-MSH-Induced Pigmentation via Modulation of AKT and p38 MAPK Signaling Pathways in B16F10 Mouse Melanoma Cells

Abstract: Dimethyl itaconate (DMI) exhibits an anti-inflammatory effect. Activation of nuclear factor erythroid 2-related factor 2 (NRF2) is implicated in the inhibition of melanogenesis. Therefore, DMI and itaconic acid (ITA), classified as NRF2 activators, have potential uses in hyperpigmentation reduction. The activity of cyclic adenosine monophosphate (cAMP) response element-binding protein (CREB), an important transcription factor for MITF gene promoter, is regulated by glycogen synthase kinase 3β (GSK3β) and prote… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 58 publications
1
2
0
Order By: Relevance
“…In brief, the α-MSH-cAMP-CREB, Wnt/β-catenin, and MAPK signaling pathways are inhibited, resulting in the downregulation of MITF expression within the dorsal skin of D0 goslings. This inhibition results in decreased expression of melanogenesis genes such as dopachrome tautomerase (DCT), tyrosinase (TYR ), and tyrosinaserelated protein 1 (TYRP1) in melanocytes [64][65][66], as observed in our RNA-seq and qRT-PCR analyses. A similar study indicated a significant decrease in the expression of these genes from E15 to E28 in geese [67], and these genes became undetectable by E29.…”
Section: Discussionsupporting
confidence: 62%
“…In brief, the α-MSH-cAMP-CREB, Wnt/β-catenin, and MAPK signaling pathways are inhibited, resulting in the downregulation of MITF expression within the dorsal skin of D0 goslings. This inhibition results in decreased expression of melanogenesis genes such as dopachrome tautomerase (DCT), tyrosinase (TYR ), and tyrosinaserelated protein 1 (TYRP1) in melanocytes [64][65][66], as observed in our RNA-seq and qRT-PCR analyses. A similar study indicated a significant decrease in the expression of these genes from E15 to E28 in geese [67], and these genes became undetectable by E29.…”
Section: Discussionsupporting
confidence: 62%
“…Previously, Shin et al have demonstrated that adenoviral expression of NRF2 or treatment of wortmannin using as an inhibitor of the PI3K/AKT signaling pathway suppressed melanogenesis in normal human melanocytes (NHMCs) [ 37 ]. On the other hand, Jang et al have demonstrated that treatment of DMI reduced α-MSH-induced pigmentation by increasing AKT activation phosphorylation at Ser473 in B16F10 cells [ 38 ]. While the role of the PI3K/AKT pathway in the inhibition of melanogenesis by DMI is still enigmatic, we have demonstrated that DMI inhibits MITF ( Figure 3 ) and its melanogenic targets such as TYR, TRP-1, and TRP-2 ( Figure 2 ) by affecting the α-MSH/MC1R-ERK1/2-MITF axis ( Figure 4 ).…”
Section: Discussionmentioning
confidence: 99%
“…Consistent with our ndings, several previous studies [23,[26][27][28][29] have reported similar results from transcriptome and RNA-seq analysis of poultry skin feather follicles, demonstrating a notable enrichment of genes in both the Wnt signaling pathway and melanogenesis process. These signaling pathways play a pivotal role in the development of melanocytes and melanin biosynthesis [30][31][32], regulating the expression of key regulatory factors like melanocortin 1 receptor (MC1R), dopachrome tautomerase (DCT), tyrosinase(TYR), tyrosinase-related protein 1 (TYRP1), and microphthalmia transcription factor (MITF), thereby determining the levels of melanin production [33][34][35]. In our RNA-seq and qRT-PCR analysis, we observed a signi cant down-regulation or even silencing of these gene expressions within the dorsal skin of day-old goslings (Fig.…”
Section: Discussionmentioning
confidence: 99%